# China NMPA Drug Inspection - Sinopharm Group Weichida Pharmaceutical Co., Ltd. - Amoxicillin Clavulanate Potassium Tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/sinopharm-group-weichida-pharmaceutical-co-ltd/d8f48e31-1f19-4f3a-8513-e7b99214ee37/
Source feed: China

> China NMPA drug inspection for Sinopharm Group Weichida Pharmaceutical Co., Ltd. published July 28, 2022. Drug: Amoxicillin Clavulanate Potassium Tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 1, 2022)
- Company Name: Sinopharm Group Weichida Pharmaceutical Co., Ltd.
- Publication Date: 2022-07-28
- Drug Name: Amoxicillin Clavulanate Potassium Tablets
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/sinopharm-group-weichida-pharmaceutical-co-ltd/6d30d149-8930-4496-a20e-c82d8224efcc/